Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Enzira (2013/2014) in Healthy Adults
NCT01863433Phase 4Completed
- Sponsor
- CSL Seqirus
- Start
- May 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Afluria in influenza, sponsored by CSL Seqirus. Started May 2013; status: completed.
02
Drugs
Afluria
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01863433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863433.